Last reviewed · How we verify
Commercial vaccine 1
Commercial vaccine 1 is a Biologic drug developed by Crucell Holland BV. It is currently in Phase 1 development. Also known as: Inflexal V (trivalent).
At a glance
| Generic name | Commercial vaccine 1 |
|---|---|
| Also known as | Inflexal V (trivalent) |
| Sponsor | Crucell Holland BV |
| Modality | Biologic |
| Phase | Phase 1 |
Approved indications
Common side effects
Key clinical trials
- Phase 1/2 Study of a Plant-Based Seasonal Recombinant Trivalent VLP Influenza Vaccine (PHASE1, PHASE2)
- Zoster Vaccine to Enhance Protection Against Zoster in Solid-organ Transplantation (PHASE2)
- A Randomised Controlled Phase 1 Study of Vaccine Therapy for Control or Cure of Chronic Hepatitis B Virus Infection (PHASE1, PHASE2)
- Clinical Trial for Batch Consistency of EV71 Vaccine (PHASE4)
- Dose Escalation Trial of CD40.HIVRI.Env Vaccine Combined or Not With a DNA-HIV-PT123 HIV-1 Vaccine in Healthy Volunteers (PHASE1)
- Phase III Clinical Trial of Lot-to-lot Consistency of Recombinant Herpes Zoster Vaccine (CHO Cell). (PHASE3)
- Immunogenicity and Safety of the Concomitant Administration of OVX836 and Quadrivalent Influenza Vaccine in Healthy Volunteers. (PHASE2)
- Safety of Sabin Inactivated Poliovirus Vaccine in Adults, Children and Infants and Lot Consistency Immunogenicity, and Safety of the msIPV in 2 Months Old Infants (PHASE3)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Commercial vaccine 1 CI brief — competitive landscape report
- Commercial vaccine 1 updates RSS · CI watch RSS
- Crucell Holland BV portfolio CI
Frequently asked questions about Commercial vaccine 1
What is Commercial vaccine 1?
Commercial vaccine 1 is a Biologic drug developed by Crucell Holland BV.
Who makes Commercial vaccine 1?
Commercial vaccine 1 is developed by Crucell Holland BV (see full Crucell Holland BV pipeline at /company/crucell-holland-bv).
Is Commercial vaccine 1 also known as anything else?
Commercial vaccine 1 is also known as Inflexal V (trivalent).
What development phase is Commercial vaccine 1 in?
Commercial vaccine 1 is in Phase 1.
Related
- Manufacturer: Crucell Holland BV — full pipeline
- Also known as: Inflexal V (trivalent)
- Compare: Commercial vaccine 1 vs similar drugs
- Pricing: Commercial vaccine 1 cost, discount & access